Author:
Caviezel Francesco,Mangili Ruggero
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference10 articles.
1. Bhathena S. J., Perrino P. V., Voyles N. R., Smith S. S., Wilkins S. D., Coy D. H., Schally A. V., Recant L.: Reversal of somatostatin inhibition of insulin and glucagon secretion — Diabetes25, 1031, 1976.
2. Cantalamessa L., Catania A., Reschini E., Peracchi M.: Inhibitory effect of calcitonin on growth hormone and insulin secretion in man - Metabolism27, 987, 1978.
3. Curry D. L., Bennett L. L.: Reversal of somatostatin inhibition of insulin secretion by calcium - Biochem. biophys. Res. Commun.60, 1015, 1974.
4. Fiore C. E., Malatino L. S., Costa M., Tamburino C., Heynen G.: Neuroendocrine modulators affecting serum calcitonin in man. In:Pecile A. (Ed.): Calcitonin 1980. Excerpta Medica, Amsterdam, 1981; p. 170.
5. Metz S. A., Deftos L. J., Baylink D. J., Robertson R. P.: Neuroendocrine modulation of calcitonin and parathyroid hormone in man - J. clin. Endocr.47, 151, 1978.